Wound Debridement Market : Growth Drivers and Leading Players

Posted on 2020-08-10 by MarketsandMarkets in Healthcare // 0 Comments

The wound debridement market is projected to reach USD 1,162 million by 2025 from USD 822 million in 2020, at a CAGR of 7.2%. Market growth is driven by the high prevalence of diabetes and associated wounds, increasing incidence of burns, and awareness programs. Emerging countries such as China and India provide growth opportunities for players in the market during the forecast period. However, the high cost of products is expected to hamper market growth to a certain extent in the coming years.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21606123

The wound debridement market is consolidated in nature. In 2019, Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), ConvaTec (UK), Mölnlycke Healthcare (Sweden), Lohmann & Rauscher (Germany), Integra Lifesciences (US), Zimmer Biomet (US), Misonix (US), and Paul Hartmann AG (Germany) were the leading players.

Smith & Nephew offers a wide range of products in the wound debridement market, such as surgical devices, gels, and ointments. Due to its well-established product portfolio and good brand image, the company is able to maintain its leading position in the wound debridement market. In addition to this, the company has a direct presence in more than 100 countries across the globe. Moreover, the company has well-established distribution channels in developed markets such as the US. It generated ~50% of its revenue from the US alone in 2019.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21606123

B. Braun offers a wide range of gel products and pads for wound debridement. The company has a strong presence and well-established distribution channels across Europe, North America, and the APAC. Moreover, it has a good brand image in the wound care segment. All these factors have enabled it to become the second-largest player in the wound debridement market. In the coming years, the company can maintain its market leadership if it focuses on ointments, gauzes, and surgical instruments.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Matched content

Editor’s pick